Technology | June 20, 2011

New SPECT System Addresses Need for Accessible Healthcare Technology at Low Dose

June 8, 2011 – GE Healthcare is offering a new fully upgradeable single photon emission computed tomography (SPECT) technology that allows patient dose as low as 50 percent of those of standard nuclear medicine scanning protocols, or the potential for patients to spend significantly less time on the table during exams, all without compromising image quality.

The new GE Healthcare Discovery NM630 is engineered to help accommodate more patients than previous-generation GE nuclear medicine systems. With its large 28-inch (70 cm) wide bore and table capable of handling patients up to 500 pounds (227 kg), the Discovery NM630 provides access to a wide variety of patient sizes.

The more precise the information healthcare providers can get about a patient’s condition, the more effectively that patient can be treated. Elite NXT detectors are designed to offer good SPECT resolution and contrast for superb image quality, all to help clinicians diagnose patients earlier and more accurately. Ultra-thin design and auto-body contouring minimize the distance between the patient and the detectors for good resolution, while SPECT-optimized collimators and the high count rate enable precise event detection.

Evolution technology changes the relationship between time, dosage and image quality by allowing clinicians to reduce time or injected patient dose by up to 50 percent in most scanning procedures while maintaining image quality.

Discovery NM 630 ignites streamlined workflow by offering half-time imaging and fast and flexible robotic gantry motions to enable a whole body and SPECT bone protocol in 15 minutes.

The Discovery NM630 can be upgraded on location to a Discovery NM/CT 670 by adding computed tomography (CT) capabilities that can expand services to true hybrid imaging, helping to protect clinicians’ investment through the ability to expand diagnostic horizons as the practice requires and the care mission demands.

The advanced Xeleris workstation, which integrates new and existing nuclear medicine equipment, including legacy GE and non-GE devices, is designed to provide consistent results and enhanced workflow. Xeleris can keep clinicians connected to images and applications from picture archiving and communications systems (PACS) and PCs within their institution and remotely.

For more information: www.gehealthcare.com

Related Content

New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Emerging Trends in Nuclear Medicine
Feature | Nuclear Imaging | June 04, 2018 | By Jeff Zagoudis
Nuclear imaging and its various modalities have long played an important role in the diagnosis and treatment of numer
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Overlay Init